Search clinical trials for: Staccato alprazolam

Total 139 results

UCB Biopharma SRL

Recruiting

A Study to Test the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures

Stereotypical Prolonged Seizures

United States, Bulgaria, China, Czechia, Germany, Hungary, Italy, Japan, Poland, Spain, United Kingdom, France, Australia
UCB Biopharma SRL

Enrolling by invitation

A Study to Test the Safety and Tolerability of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures

Stereotypical Prolonged Seizures

United States, Bulgaria, China, Czechia, Germany, Hungary, Italy, Japan, Poland, Spain, United Kingdom, Australia
UCB Biopharma SRL

Completed

A Relative Bioavailability Study of Staccato Alprazolam Versus Oral Alprazolam in Healthy Study Participants

Healthy Participants

United States
UCB Biopharma SRL

Completed

A Study to Assess the Pulmonary Safety of Staccato Alprazolam in Healthy Study Participants and in Study Participants With Mild Asthma

Healthy Study Participants | Participants With Mild Asthma

United States
UCB Biopharma SRL

Completed

A Study to Assess the Pharmacokinetics (PK) and Safety of Staccato Alprazolam in Adolescent Study Participants With Epilepsy

Epilepsy

United States
Engage Therapeutics, Inc.
Clinilabs, Inc.

Completed

Pharmacokinetic Study Evaluating Staccato® Alprazolam 1 mg Inhaler in Smokers Versus Non-Smokers

Healthy

United States
Alexza Pharmaceuticals, Inc.
The Epilepsy Study Consortium

Completed

Staccato Alprazolam and Photoparoxysmal Response

Epilepsy

United States
UCB Biopharma SRL

Completed

Study to Assess the Safety, Tolerability, And Pharmacokinetics of Staccato Alprazolam in Healthy Japanese, Chinese, and Caucasian Participants

Healthy Study Participants

United States
Engage Therapeutics, Inc.

Completed

Inpatient, Dose-Ranging Study of Staccato Alprazolam in Epilepsy With Predictable Seizure Pattern (StATES)

Epilepsy

Australia, United States, Jamaica
Alexza Pharmaceuticals, Inc.

Completed

Staccato Alprazolam Abuse Liability

Abuse Liability of Staccato Alprazolam

United States
Alexza Pharmaceuticals, Inc.

Completed

Staccato Alprazolam in Panic Attack

Treatment of Induced Panic Attack

United States
Alexza Pharmaceuticals, Inc.

Completed

Staccato Alprazolam Single Dose PK

Healthy
The Cleveland Clinic

Recruiting

Functional Brain Network Changes in Patients Undergoing Deep Brain Stimulation for Essential Tremor (TRaNCE)

Essential Tremor

United States
Sultan Qaboos University

Not yet recruiting

Efficacy of Hydroxyzine for Patients With Panic Disorder

Panic Disorder
Wayne State University
Henry Ford Health System

Recruiting

Opioid/Benzodiazepine Polydrug Abuse: Aim 3 (MAP)

Opioid Abuse | Benzodiazepine Abuse | Polysubstance Abuse

United States
University of California, San Francisco
Flight Attendant Medical Research Institute

Recruiting

Secondhand Tobacco Smoke and Cardiovascular Disease

Cardiovascular Diseases | Hypertension

United States
University of California, San Francisco
Khon Kaen University; King Chulalongkorn Memorial Hospital; Huang Pacific Foundation

Recruiting

Systemic and Topical Antivirals for Control of Cytomegalovirus Anterior Uveitis: Treatment Outcomes (STACCATO)

Cytomegalovirus Anterior Uveitis

Thailand, United States
Central Hospital, Nancy, France

Recruiting

Preoperative Hypnosis Versus Premedication in Gynecological Surgery (HYPNOGYN)

Gynecologic Disease | Anxiety Disease

France
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Alprazolam Extended-Release Tablets 1 mg to Xanax XR Tablets 1 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fed Study of Alprazolam Extended-release Tablets 3 mg to Xanax XR® Tablets 3 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Alprazolam Extended-Release Tablets 3 mg to Xanax XR® Tablets 3 mg

Healthy

United States
Azurity Pharmaceuticals

Completed

An Abuse Potential Study of Orally Administered HORIZANT in Healthy, Non-dependent, Recreational Drug Users

Abuse Potential

United States
Pachankis, Yang I., M.D.
First Affiliated Hospital of Chongqing Medical University

Completed

Detoxification From the Lipid Tract

COVID-19 Vaccine Adverse Reaction

China
Alexza Pharmaceuticals, Inc.
ISS, Inc.; DSG; Peachtree BioResearch Solutions

Terminated

Study to Evaluate the Efficacy and Safety of Staccato Apomorphine (AZ-009) in Patients With Parkinson's Disease Experiencing OFF Episodes

Parkinson Disease

United States
Janssen Vaccines & Prevention B.V.

Completed

A Study to Evaluate A Range of Dose Levels of Ad26.ZEBOV and MVA-BN-Filo in Healthy Adult Participants

Healthy

United States
National Institute of Allergy and Infectious Diseases...
London School of Hygiene and Tropical Medicine; Institut National de la Santé... and other collaborators

Active, not recruiting

Partnership for Research on Ebola VACcinations (PREVAC)

Ebola Virus Disease

Guinea, Liberia, Mali, Sierra Leone
University of Nebraska
National Cancer Institute (NCI)

Completed

Paclitaxel, Cyclophosphamide & Doxorubicin, Autologous Dendritic Cells & Surgery in Stage II/III Breast Cancer (Women)

Breast Cancer

United States
Timothy L. Brown
National Highway Traffic Safety Administration (NHTSA); Cognitive Research... and other collaborators

Completed

Validation of the Drug Impaired Driving Scenario (DIDS) on the CRCDS-miniSim (PDID)

Driving Under the Influence | Driving Behavior

United States
Takeda

Completed

A Study of Soticlestat in Healthy Adult Nondependent Recreational Drug Users With Central Nervous System (CNS) Depressant Experience

Healthy Volunteers

United States
Saga University

Active, not recruiting

Program of Angiotensin-Neprilysin Inhibition in Admitted Patients With Worsening Heart Failure (PREMIER)

Heart Failure

Japan
University of Illinois at Chicago
Oregon State University

Completed

Licorice Botanical Dietary Supplements - Metabolism and Safety in Women

Food-drug Interaction

United States
Universitaire Ziekenhuizen KU Leuven

Completed

STACCATO: Stent sTrut Apposition and Coverage in Coronary ArTeries: an Optical Coherence Tomography (OCT) Study (STACCATO)

Coronary Artery Disease

Belgium
Providence Health & Services
Multiple Sclerosis Center of Northeastern New York

Completed

MAIN STUDY: SWITCH SUB-STUDY: SWITCH-JCV

Multiple Sclerosis

United States
Per-Ola Carlsson
Diamyd Medical AB

Completed

Evaluation of Safety and Diabetes Status Upon Oral Treatment With GABA in Patients With Longstanding Type-1 Diabetes

Type 1 Diabetes Mellitus

Sweden
Alexza Pharmaceuticals, Inc.

Completed

Staccato Granisetron® (AZ 010) for the Treatment of Cyclic Vomiting Syndrome

Cyclic Vomiting Syndrome

United States
Cerevel Therapeutics, LLC

Completed

A Trial of the Effect of CVL-865 on Panic Symptoms Induced by Carbon Dioxide Inhalation in Healthy Subjects

Panic Disorder

Netherlands
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Study to Assess the Safety and Pharmacokinetics of ADASUVE® at Doses of 2.5, 5, or 10 mg in Children and Adolescents (10 Through 17 Years of Age) With Any Condition Warranting Chronic Use of an Antipsychotic Medication

BiPolar

United States
University of Buenos Aires

Completed

Efficacy of Aerobic Exercise Added to Alprazolam in Panic Disorder Treatment (AEIPDT)

Panic Disorder

Argentina
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Bioequivalence of Alprazolam Sublingual vs Oral Tablets

Healthy

India
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Evaluate Pharmacokinetics Of Two Different Pharmaceutical Oral Formulations Of Alprazolam And A Clonazepam Tablet In Mexican Healthy Population

Pharmacokinetics

Mexico
Pfizer's Upjohn has merged with Mylan to form Viatris...

Withdrawn

Bioequivalence Of A Test Alprazolam Sublingual Formulation Compared To A Commercial Sublingual Formulation

Healthy
Pfizer's Upjohn has merged with Mylan to form Viatris...

Terminated

A Study To Assess the Safety of Extended Release Alprazolam for the Treatment of Adolescents With Panic Disorder or Anxiety With Panic Attacks

Panic Disorder

United States
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

A Bioequivalence Study Of A New Alprazolam Dropped Formulation Versus Alprazolam Tablets

Healthy

Brazil
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Pharmacokinetics Of Alprazolam Sublingual Tablet Versus Conventional Tablet

Anxiety Disorder

United States
Pfizer's Upjohn has merged with Mylan to form Viatris...

Terminated

A Study to Evaluate the Use of Extended Release Alprazolam in the Treatment of Adolescents With Panic Disorder

Panic Disorder

United States
Pfizer's Upjohn has merged with Mylan to form Viatris...

Withdrawn

Bioequivalence of a New and a Commercial Alprazolam Sublingual Formulation

Healthy
Pfizer's Upjohn has merged with Mylan to form Viatris...

Withdrawn

Bioequivalence of a New Sublingual and a Reference Alprazolam Immediate Release Tablet Formulation

Healthy
Pfizer's Upjohn has merged with Mylan to form Viatris...

Terminated

A Study to Assess the Long-term Use of Alprazolam Extended Release (XL) in the Treatment of Adolescents With Panic Disorder

Panic Disorder

United States
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

An Bioequivalence Study Of Xanax Extended Release Tablets From Two Different Manufacturing Sites

Healthy Subjects

Singapore
Pfizer's Upjohn has merged with Mylan to form Viatris...
Investigacion Farmacologica y Biofarmaceutica, S.A. de C.V.

Withdrawn

A Study Of Two Oral Preparations Of 2 Mg Alprazolam In Healthy Volunteers Under Fasting Conditions

Healthy

Search clinical trials for: Staccato alprazolam

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Angola

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations